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Programmed necrosis has long been recognized as a crucial component of animal development;
however, the signaling pathway beyond the protein kinases RIP1 and RIP3 remains largely
unknown. Sun et al. and Wang et al. now identify critical factors downstream of RIP1 and RIP3 in
programmed necrosis, extending our understanding of this form of cell death.Cell death by necrosis, unlike other forms
of programmed cell death, is immuno-
genic and associated with many disease
pathologies. Recent work indicates that
death cytokines in the TNF family can
induce a ‘‘programmed’’ form of necrosis
through the kinases RIP1 and RIP3 when
caspases are inhibited. Genetic experi-
ments have recently determined that
RIP1- and RIP3-driven programmed ne-
crosis is crucial during embryonic devel-
opment, certain viral infections, tissue
injury/inflammation, and clonal expan-
sion of antigen-specific lymphocytes (re-
viewed in Oberst and Green, 2011).
Beyond RIP1 and RIP3, however, our
understanding of the molecular regulation
of programmed necrosis remains limited.
In this issue of Cell, Wang and colleagues
provide convincing evidence that mixed
lineage kinase domain-like (MLKL) and
phosphoglycerate mutase 5 (PGAM5)
are integral parts of the necrosis signaling
machinery downstream of RIP1 and RIP3
activation and are RIP3 substrates (Sun
et al., 2012; Wang et al., 2012).
RIP1 is a critical adaptor for NF-kB acti-
vation through multiple immune signaling
receptors. Paradoxically, it also mediates
cell death by apoptosis and programmed
necrosis. Necrosis signaling by RIP1 re-
quires interaction with RIP3. Unlike RIP1,
RIP3 does not participate in NF-kB or
apoptosis signaling (Moquin and Chan,
2010). Because the kinase functions of
RIP1 and RIP3 are essential for program-
med necrosis, identifying their substrates
holds the key in understanding the regula-
tion of this poorly defined process. Phar-
macological inhibition of RIP1 abolished
RIP3 recruitment and activation of the
necrosis-inducing complex, suggestingthat RIP1 is likely the upstream activating
kinase for RIP3 (Cho et al., 2009; He et al.,
2009). By contrast, the substrates of RIP3
have remained elusive. Although mito-
chondrial enzymes were previously impli-
cated as substrates for RIP3, their roles
in programmed necrosis have yet to be
independently validated (Zhang et al.,
2009).
To identify putative RIP3 substrates,
Sun et al. use a chemical library screening
approach to identify a small molecule
named necrosulfonamide (NSA) that
blocks programmed necrosis down-
stream of RIP3. NSA inhibits necrosis
by covalently modifying a protein called
mixed lineage kinase domain-like pro-
tein (MLKL). Interestingly, NSA covalently
modifies a cysteine present in human
MLKL, but not in mouse MLKL, giving
the compound species specificity. MLKL
interacts directly with RIP3, and reducing
the levels of MLKL protects cells against
TNF-induced necrosis. Sun et al. also
show that, upon necrosis induction,
MLKL is strongly recruited to phosphory-
lated RIP3 and is subsequently phos-
phorylated by RIP3. Mutation of these
phosphorylation sites onMLKL abrogates
the ability of RIP3 and MLKL to signal for
necrosis. These results establish MLKL
as a functional substrate of RIP3 and sug-
gest that MLKL functions as a key medi-
ator of necrosis signaling.
Small-molecule inhibitors have signifi-
cantly advanced our understanding of
programmed necrosis. The RIP1 kinase
inhibitor necrostatin-1 (Nec-1) (Degterev
et al., 2008) and NSA inhibit distinct steps
of programmed necrosis and provide crit-
ical insight into the hierarchical relation-
ships among the factors controlling thisCell 14process. Unlike Nec-1, NSA inhibits
necrosis by covalently modifying MLKL.
Because MLKL does not possess en-
zymatic function, it likely serves as an
adaptor to bring the RIP1-RIP3 necro-
some complex into proximity with other
RIP3 substrates and downstream effec-
tors (Figure 1). In another study from the
same laboratory, Wang et al. use NSA to
identify the mitochondrial protein phos-
phatase, PGAM5, as one of these down-
stream effectors.
Genetic evidence in Drosophila sug-
gests that PGAM5 regulates the func-
tion of the Parkinson’s disease gene
PINK1, suggesting a possible link
between necrosis and neurodegeneration
(Imai et al., 2010). PGAM5 has two splice
variants, PGAM5L and PGAM5S, and
each one appears to have a distinct func-
tion in necrosis. In the presence of NSA,
MLKL and PGAM5L binding to RIP3
is enhanced, and phosphorylation of
PGAM5L by RIP3 is unaffected. Interest-
ingly, the phosphorylation of PGAM5S
is abolished in the presence of NSA,
suggesting that the inhibitor likely stabi-
lizes the RIP3 complex and prevents it
from engaging the downstream effector
PGAM5S. Thus, it appears that PGAM5L
tethers the RIP1-RIP3-MLKL necrosome
(complex II) to PGAM5S on the mitochon-
drial membrane (Figure 1).
Mitochondrial fragmentation has been
implicated in cell death. The association
of the necrosome with PGAM5S appears
to be a critical event for activation of
Drp1, a GTPase that is essential for mito-
chondrial fission. PGAM5L dephosphory-
lates Drp-1 and activates its GTPase
activity. Thus, RIP1-RIP3-MLKL-PGAM5L
form a dynamic and transient complex8, January 20, 2012 ª2012 Elsevier Inc. 17
Figure 1. Sequential Recruitment and Activation of Necrosis Signaling Complexes
RIP1 is recruited to the activated TNFR-1 and undergoes heavy ubiquitination by E3 ligases such as
TRAF2 and cIAP-1. This membrane- and receptor-associated complex, termed complex I, is responsible
for NF-kB activation. As themembrane-associated complex I becomes internalized, deubiquitinases such
as cylindromatosis (CYLD) removes the polyubiquitin chains on RIP1. The deubiquitination of RIP1 and
inhibition of caspase 8 are crucial for the assembly of the secondary signaling complex (complex II). At this
cytoplasmic complex, RIP1 likely phosphorylates RIP3 at S227, which in turn phosphorylates PGAM5L
and MLKL at T357 and S358. These phosphorylation events are important for the RIP3 necrosis signaling
complex to engage PGAM5S on the mitochondrial membrane, a step that is inhibited by the small-
molecule inhibitor NSA. Once activated by phosphorylation, the PGAM5L/PGAM5S complex dephos-
phorylates the mitochondrial fission regulator Drp1 to induce its dimerization and activation. Excessive
Drp1 activity could lead to disruption of mitochondrial functions and other organelle and membrane
damages that cumulate in programmed necrosis. The PGAM5L-PGAM5S-Drp1 mitochondrial attack
complex (MAC) could also be activated by calcium flux or a surge of intracellular reactive oxygen
species (ROS).that dissolves over time as the tertiary
complex of PGAM5S-Drp-1 (complex III)
becomes activated (Figure 1). RNAi-medi-
ated silencing of MLKL, PGAM5, or Drp-1
or pharmacological inhibition of Drp-1
prevents mitochondrial fragmentation and
necrosis. These results suggest a tanta-
lizing mechanism in which the RIP1-RIP3
necrosome complex signals for necrosis
by engaging the mitochondrial fission
machinery.
Significantly, the ‘‘mitochondria attack
complex’’ consisting of PGAM5 and
Drp-1, but neither RIP1, RIP3, nor MLKL,18 Cell 148, January 20, 2012 ª2012 Elsevieris also required for necrosis induced by
signals such as calcium flux and oxidative
stress. Thus, these results provide strong
evidence that extrinsic death receptor-
mediated (e.g., TNF-like death cytokines)
and intrinsic death receptor-independent
signals (e.g., oxidative stress) converge
upon the PGAM5-Drp-1 axis to induce
necrosis.
These studies provide a significant
advance in our understanding of pro-
grammed necrosis by identifying two
downstream effectors of this process.
More remains to be learned about MLKLInc.and PGAM5, including the specificity of
their roles in programmed necrosis and
whether they are required for all necrosis
that occurs in animals. Furthermore, the
role of Drp-1 in necrosis needs to be
further investigated to understand how
mitochondrial fragmentation promotes
this form of cell death. Necrotic cell death
has long been neglected as a process
lacking physiological relevance. Times
have changed, and with broad physio-
logical implications, a blueprint for pro-
grammed necrosis is now emerging.
Much remains to be learned about how
different forms of cell death are regulated,
how they may influence each other, and
whether we can augment necrosis as a
therapeutic approach to compensate for
mutations in cell death pathways.REFERENCES
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